✦ LIBER ✦

Somatostatin and neuropeptide Y concentrations in pathologically graded cases of huntington's disease

✍ Scribed by Dr. M. Flint Beal; Michael F. Mazurek; David W. Ellison; Kenton J. Swartz; Usha McGarvey; Edward D. Bird; Joseph B. Martin

Book ID: 102708187
Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 753 KB
Volume: 23
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410230606

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Somatostatin and neuropeptide Y immunore

Somatostatin and neuropeptide Y immunoreactivity in parkinson's disease dementia with alzheimer's changes

✍ M. Flint Beal; Ross A. Clevens; Michael F. Mazurek 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

Influence of cysteamine and cysteine on

Influence of cysteamine and cysteine on open-field behaviour, and on brain concentrations of catecholamines, somatostatin, neuropeptide Y, and corticotropin releasing hormone in the rat

✍ L. Vécsei; R. Ekman; C. Alling; E. Widerlöv 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 786 KB

A novel target for Huntington's disease:

A novel target for Huntington's disease: ERK at the crossroads of signaling : The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology

✍ Bodai, László (author);Marsh, J. Lawrence (author) 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

## Abstract Activating the ERK pathway (extracellular signal‐regulated kinase pathway) has proven beneficial in several models of Huntington's disease (HD), and drugs that are protective in HD models have recently been found to activate ERK. Thus, the ERK cascade may be a potential target for thera

A novel target for Huntington's disease:

A novel target for Huntington's disease: ERK at the crossroads of signaling : The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology

✍ Bodai, László (author);Marsh, J. Lawrence (author) 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

Opposite effects of astrocyte-derived so

Opposite effects of astrocyte-derived soluble factor(s) on the functional expression of fetal peptidergic neurons in aggregate cultures: Enhancement of neuropeptide Y and suppression of somatostatin

✍ Ayalla Barnea; Nelson Aguila-Mansilla; Gang Lu; Raymond H. Ho 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 896 KB

Previous studies established that fetal rat and human neuropeptide Y (NPY) cortical neurons in aggregate cultures are differentially regulated. Whereas brain-derived neurotrophic factor (BDNF) or phorbol 12-myristate-13-acetate (PMA) induces NPY production in rat cultures, only PMA does so in human

Pathological gambling in Parkinson's dis

Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series

✍ David A. Gallagher; Sean S. O'Sullivan; Andrew H. Evans; Andrew J. Lees; Anette 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

## Abstract Pathological gambling (PG) has been reported as a complication of the treatment of Parkinson's disease (PD). We examined all published cases of PG for prevalence and risk factors of this complication, the relationship of PG and use of dopamine agonists (DA), and the relationship of PG t